For the Immunocompromised/Stem Cell Transplant patient trial ... and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to ...

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the launch of its new Global Therapy Innovations business unit, designed to integrate disease expertise ...

Avirmax's Chief Executive and Scientific Officer, Dr. Shengjiang Shawn Liu, Ph.D., will chair the upcoming session of "Acceleration of AAV Gene Therapy for Ocular Diseases: Improving Delivery and ...